BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao DX, Li ZJ, Jiang XO, Lum YL, Khin E, Lee NP, Wu GH, Luk JM. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol 2012; 18(30): 3923-3930 [PMID: 22912540 DOI: 10.3748/wjg.v18.i30.3923]
URL: https://www.wjgnet.com/1007-9327/full/v18/i30/3923.htm
Number Citing Articles
1
Ashraf Khalil, Jamalat Elgedawy, Mohammed F Faramawi, Ashraf Elfert, Ibrahim Salama, Ahmed Abbass, Hala Elsaid, Hatem Elsebaai. Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic LesionsTumori Journal 2013; 99(1): 100 doi: 10.1177/030089161309900117
2
Jawed Iqbal, Steven McRae, Krishna Banaudha, Thi Mai, Gulam Waris. Mechanism of Hepatitis C Virus (HCV)-induced Osteopontin and Its Role in Epithelial to Mesenchymal Transition of HepatocytesJournal of Biological Chemistry 2013; 288(52): 36994 doi: 10.1074/jbc.M113.492314
3
XIA YING, YUE ZHAO, JUN-LAN WANG, XIA ZHOU, JING ZHAO, CHEN-CHEN HE, XI-JING GUO, GUI-HUA JIN, LI-JUAN WANG, QING ZHU, SU-XIA HAN. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinomaOncology Reports 2014; 32(4): 1550 doi: 10.3892/or.2014.3367
4
Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk. Circulating markers for prognosis of hepatocellular carcinomaExpert Opinion on Medical Diagnostics 2013; 7(4): 319 doi: 10.1517/17530059.2013.795146
5
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular CarcinomaRadiology 2017; 285(1): 311 doi: 10.1148/radiol.2017162555
6
Beata Kaleta, Agnieszka Boguska. Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear CellsArchivum Immunologiae et Therapiae Experimentalis 2017; 65(4): 347 doi: 10.1007/s00005-017-0455-9
7
Tao Zhang, Dong-Ming Zhang, Da Zhao, Xiao-Ming Hou, Xiao-Jun Liu, Xiao-Ling Ling, Shou-Cheng Ma. The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysisJournal of Molecular Histology 2014; 45(5): 533 doi: 10.1007/s10735-014-9574-3
8
Cédric Coulouarn, Bruno Clément. Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stromaJournal of Hepatology 2014; 60(6): 1306 doi: 10.1016/j.jhep.2014.02.003
9
Beata Kaleta. Genetic Polymorphisms2017;  doi: 10.5772/intechopen.69528
10
Won-Young Cho, Seong-Ho Hong, Bijay Singh, Mohammad Ariful Islam, Somin Lee, Ah Young Lee, Nomundelger Gankhuyag, Ji-Eun Kim, Kyeong-Nam Yu, Kwang-Ho Kim, Young-Chan Park, Chong-Su Cho, Myung-Haing Cho. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNAEuropean Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 450 doi: 10.1016/j.ejpb.2015.06.017
11
Henry H. Chill, Uri P. Dior, Liron Kogan, Ariel Revel. microRNA: Basic ScienceAdvances in Experimental Medicine and Biology 2015; 887: 143 doi: 10.1007/978-3-319-22380-3_8
12
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalWorld Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
13
Beata Kaleta. Role of Osteopontin in Systemic Lupus ErythematosusArchivum Immunologiae et Therapiae Experimentalis 2014; 62(6): 475 doi: 10.1007/s00005-014-0294-x
14
Ya Cao, Dehu Chen, Weiwei Chen, Jiacui Yu, Zhong Chen, Genxi Li. Aptamer-based homogeneous protein detection using cucurbit[7]uril functionalized electrodeAnalytica Chimica Acta 2014; 812: 45 doi: 10.1016/j.aca.2014.01.008
15
Filip Mundt, Ghazal Heidari-Hamedani, Gustav Nilsonne, Muzaffer Metintas, Anders Hjerpe, Katalin Dobra. Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural MalignanciesBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/419853
16
Jing Huang, Mu Hu, Huan Niu, Jing Wang, Yang Si, Shan Cheng, Wei Ding. Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levelsBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08495-z
17
Laurent Sulpice, Michel Rayar, Mireille Desille, Bruno Turlin, Alain Fautrel, Eveline Boucher, Francisco Llamas-Gutierrez, Bernard Meunier, Karim Boudjema, Bruno Clément, Cédric Coulouarn. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinomaHepatology 2013; 58(6): 1992 doi: 10.1002/hep.26577
18
Katyana Amilca-Seba, Michèle Sabbah, Annette K. Larsen, Jérôme A. Denis. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical ApplicationsCancers 2021; 13(15): 3793 doi: 10.3390/cancers13153793
19
Monalisa Bandopadhyay, Anuradha Bulbule, Ramesh Butti, Goutam Chakraborty, Priyanka Ghorpade, Pompom Ghosh, Mahadeo Gorain, Smita Kale, Dhiraj Kumar, Santosh Kumar, Kumar VS Totakura, Gaurab Roy, Priyanka Sharma, Dattatrya Shetti, Gowrishankar Soundararajan, Dhanashri Thorat, Deepti Tomar, Radha Nalukurthi, Remya Raja, Rosalin Mishra, Amit S Yadav, Gopal C Kundu. Osteopontin as a therapeutic target for cancerExpert Opinion on Therapeutic Targets 2014; 18(8): 883 doi: 10.1517/14728222.2014.925447
20
Mahipal Singh, Suman Dalal, Krishna Singh. Osteopontin: At the cross-roads of myocyte survival and myocardial functionLife Sciences 2014; 118(1): 1 doi: 10.1016/j.lfs.2014.09.014
21
Hanne Haslene-Hox, Amina Madani, Kaja C.G. Berg, Kathrine Woie, Helga B. Salvesen, Helge Wiig, Olav Tenstad. Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and bloodBBA Clinical 2014; 2: 18 doi: 10.1016/j.bbacli.2014.08.002
22
Mingfei Zhao, Hangdi Xu, Feng Liang, Jiliang He, Jianmin Zhang. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysisTumor Biology 2015; 36(1): 429 doi: 10.1007/s13277-014-2645-y
23
Timea Kiss, Szilvia Ecsedi, Laura Vizkeleti, Viktoria Koroknai, Gabriella Emri, Nora Kovács, Roza Adany, Margit Balazs. The role of osteopontin expression in melanoma progressionTumor Biology 2015; 36(10): 7841 doi: 10.1007/s13277-015-3495-y
24
Giovanni Musso, Elena Paschetta, Roberto Gambino, Maurizio Cassader, Federica Molinaro. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liverTrends in Molecular Medicine 2013; 19(9): 522 doi: 10.1016/j.molmed.2013.05.006
25
Mourad Assidi, Wafaey Gomaa, Mohammad Jafri, Mehenaz Hanbazazh, Mahmoud Al-Ahwal, Peter Pushparaj, Asia Al-Harbi, Mohammed Al-Qahtani, Abdelbaset Buhmeida, Jaudah Al-Maghrabi. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approachTumor Biology 2019; 41(9): 101042831986362 doi: 10.1177/1010428319863627
26
Jingdong Du, Huadong Mao, Hong Ouyang, Yan Xin. Osteopontin Induced Vascular Endothelial Growth Factor Production in Dispersed Nasal Polyp Cells through the Phosphatidylinositol 3-Kinase–Protein Kinase B and the Extracellular Signal-Regulated Kinase 1/2 PathwaysAmerican Journal of Rhinology & Allergy 2017; 31(4): e35 doi: 10.2500/ajra.2017.31.4449
27
Xiaocong Pang, Kan Gong, Xiaodan Zhang, Shiliang Wu, Yimin Cui, Bin-Zhi Qian. Osteopontin as a multifaceted driver of bone metastasis and drug resistancePharmacological Research 2019; 144: 235 doi: 10.1016/j.phrs.2019.04.030
28
Iman A. Mohamed, Fatima Mraiche. Targeting Osteopontin, the Silent Partner of Na+/H+Exchanger Isoform 1 in Cardiac RemodelingJournal of Cellular Physiology 2015; 230(9): 2006 doi: 10.1002/jcp.24958
29
Andrew J. Sawyer, Themis R. Kyriakides. Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationAdvanced Drug Delivery Reviews 2016; 97: 56 doi: 10.1016/j.addr.2015.12.016
30
Ali Nazarizadeh, Shahin Alizadeh-Fanalou, Ameinh Hosseini, Alireza Mirzaei, Vahid Salimi, Hadi keshipour, Banafsheh Safizadeh, Khodamorad Jamshidi, Mehrdad Bahrabadi, Masoumeh Tavakoli-Yaraki. Evaluation of local and circulating osteopontin in malignant and benign primary bone tumorsJournal of Bone Oncology 2021; 29: 100377 doi: 10.1016/j.jbo.2021.100377
31
Yanzhang Hao, Jianwei Liu, Ping Wang, Feng Wang, Zeshun Yu, Mianli Li, Shaoshui Chen, Fangling Ning. OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLCInternational Journal of Genomics 2014; 2014: 1 doi: 10.1155/2014/846142
32
Patricia Aguilar-Melero, María-José Prieto-Álamo, Juan Jurado, Arne Holmgren, Carmen Pueyo. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1Journal of Proteomics 2013; 79: 161 doi: 10.1016/j.jprot.2012.12.005
33
Ana I. Pérez-Hernández, Victoria Catalán, Javier Gómez-Ambrosi, Amaia Rodríguez, Gema Frühbeck. Mechanisms Linking Excess Adiposity and Carcinogenesis PromotionFrontiers in Endocrinology 2014; 5 doi: 10.3389/fendo.2014.00065
34
Junjun Li, Ming Yan, Zilu Wang, Shuanglin Jing, Yao Li, Genxia Liu, Jinhua Yu, Zhipeng Fan. Effects of Canonical NF-κB Signaling Pathway on the Proliferation and Odonto/Osteogenic Differentiation of Human Stem Cells from Apical PapillaBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/319651
35
Xingwen Han, Wenji Wang, Jingjing He, Lei Jiang, Xun Li. Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.9905
36
Anai Kothari, Matthew Arffa, Victor Chang, Robert Blackwell, Wing-Kin Syn, Jiwang Zhang, Zhiyong Mi, Paul Kuo. Osteopontin—A Master Regulator of Epithelial-Mesenchymal TransitionJournal of Clinical Medicine 2016; 5(4): 39 doi: 10.3390/jcm5040039
37
Xiaobin Gu, Xian-Shu Gao, Mingwei Ma, Shangbin Qin, Xin Qi, Xiaoying Li, Shaoqian Sun, Hao Yu, Wen Wang, Dong Zhou. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysisOncotarget 2016; 7(43): 69666 doi: 10.18632/oncotarget.11936
38
Maria Di Bartolomeo, Filippo Pietrantonio, Alessandro Pellegrinelli, Antonia Martinetti, Luigi Mariani, Maria Grazia Daidone, Emilio Bajetta, Giuseppe Pelosi, Filippo de Braud, Irene Floriani, Rosalba Miceli. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancerGastric Cancer 2016; 19(2): 412 doi: 10.1007/s10120-015-0495-y
39
Adam L. Washburn, Winnie W. Shia, Kimberly A. Lenkeit, So-Hyun Lee, Ryan C. Bailey. Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arraysThe Analyst 2016; 141(18): 5358 doi: 10.1039/C6AN01076H
40
Manuela Cabiati, Melania Gaggini, Maria Michela Cesare, Chiara Caselli, Paolo De Simone, Franco Filipponi, Giuseppina Basta, Amalia Gastaldelli, Silvia Del Ry. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-upCytokine 2017; 99: 59 doi: 10.1016/j.cyto.2017.07.004
41
Xin-Lin Wu, Kai-Jin Lin, Ai-Ping Bai, Wan-Xiang Wang, Xing-Kai Meng, Xiu-Lan Su, Ming-Xing Hou, Pei-De Dong, Jun-Jing Zhang, Zhao-Yang Wang, Lin Shi. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cellsWorld Journal of Gastroenterology 2014; 20(30): 10440-10448 doi: 10.3748/wjg.v20.i30.10440
42
Otília Menyhárt, Ádám Nagy, Balázs Győrffy. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinomaRoyal Society Open Science 2018; 5(12): 181006 doi: 10.1098/rsos.181006
43
Casimiro Gerarduzzi, Ursula Hartmann, Andrew Leask, Elliot Drobetsky. The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer MicroenvironmentCancer Research 2020; 80(13): 2705 doi: 10.1158/0008-5472.CAN-18-2098
44
Jawed Iqbal, Mehuli Sarkar-Dutta, Steven McRae, Akshaya Ramachandran, Binod Kumar, Gulam Waris, Michael S. Diamond. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44Journal of Virology 2018; 92(13) doi: 10.1128/JVI.02116-17
45
Zhi-De Hu, Xiao-Fei Liu, Xiao-Cui Liu, Chun-Mei Ding, Cheng-Jin Hu. Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysisClinica Chimica Acta 2014; 433: 44 doi: 10.1016/j.cca.2014.02.024
46
Suman Dalal, Qinqin Zha, Christopher R. Daniels, Rebecca J. Steagall, William L. Joyner, Alain-Pierre Gadeau, Mahipal Singh, Krishna Singh. Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stressAmerican Journal of Physiology-Heart and Circulatory Physiology 2014; 306(8): H1182 doi: 10.1152/ajpheart.00954.2013
47
Claudio Guarneri, Valentina Bevelacqua, Jerry Polesel, Luca Falzone, Patrizia S. Cannavò, Demetrios A. Spandidos, Grazia Malaponte, Massimo Libra. NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanomaOncology Reports 2017; 37(2): 737 doi: 10.3892/or.2017.5362
48
Xianhua Shi, Linxi Chen, Siyi Chen, Duanping Sun. Electrochemical aptasensors for the detection of hepatocellular carcinoma-related biomarkersNew Journal of Chemistry 2021;  doi: 10.1039/D1NJ01042E
49
Roxana C. Mustata, Gabriela Vasile, Valeria Fernandez-Vallone, Sandra Strollo, Anne Lefort, Frédérick Libert, Daniel Monteyne, David Pérez-Morga, Gilbert Vassart, Marie-Isabelle Garcia. Identification of Lgr5-Independent Spheroid-Generating Progenitors of the Mouse Fetal Intestinal EpitheliumCell Reports 2013; 5(2): 421 doi: 10.1016/j.celrep.2013.09.005
50
Margareta Žlajpah, Emanuela Boštjančič, Nina Zidar. (Epi)genetic regulation of osteopontin in colorectal cancerogenesisEpigenomics 2020; 12(16): 1389 doi: 10.2217/epi-2020-0032